| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
|
12,790 |
7,713 |
$328K |
| 99214 |
|
7,112 |
4,008 |
$235K |
| 99291 |
|
3,732 |
921 |
$127K |
| 94010 |
|
15,569 |
9,325 |
$101K |
| 99233 |
Prolong inpt eval add15 m |
8,043 |
2,556 |
$101K |
| 94729 |
|
4,532 |
2,879 |
$48K |
| 94060 |
|
1,473 |
1,045 |
$26K |
| 87635 |
|
367 |
350 |
$18K |
| 94726 |
|
1,022 |
735 |
$16K |
| 96372 |
|
553 |
366 |
$10K |
| 99244 |
|
64 |
54 |
$6K |
| 99232 |
|
534 |
204 |
$5K |
| 99442 |
|
141 |
87 |
$2K |
| 99223 |
Prolong inpt eval add15 m |
81 |
37 |
$853.20 |
| 99441 |
|
154 |
110 |
$836.89 |
| 99443 |
|
25 |
13 |
$467.92 |
| 90686 |
|
25 |
14 |
$209.33 |
| 99222 |
|
61 |
24 |
$186.28 |
| 90471 |
|
97 |
58 |
$105.12 |
| 99406 |
|
15 |
14 |
$98.28 |
| 94664 |
|
20 |
13 |
$82.80 |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
1,200 |
756 |
$63.20 |
| A7003 |
Administration set, with small volume nonfiltered pneumatic nebulizer, disposable |
804 |
686 |
$57.04 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
440 |
408 |
$14.44 |
| J2357 |
Injection, omalizumab, 5 mg |
55 |
50 |
$0.00 |
| 99058 |
|
19 |
12 |
$0.00 |
| 99072 |
|
1,936 |
1,453 |
$0.00 |